ES2065254A1 - Peptides and synthetic vaccines against canine Parvovirus and other related viruses - Google Patents

Peptides and synthetic vaccines against canine Parvovirus and other related viruses

Info

Publication number
ES2065254A1
ES2065254A1 ES09300117A ES9300117A ES2065254A1 ES 2065254 A1 ES2065254 A1 ES 2065254A1 ES 09300117 A ES09300117 A ES 09300117A ES 9300117 A ES9300117 A ES 9300117A ES 2065254 A1 ES2065254 A1 ES 2065254A1
Authority
ES
Spain
Prior art keywords
peptides
related viruses
canine parvovirus
vaccines against
against canine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09300117A
Other languages
Spanish (es)
Other versions
ES2065254B1 (en
Inventor
Alvarez Jose Ignacio Casal
Olmo Carmen Vela
Joannes Pieter Langeveld
Robert Hans Meloen
Kristian Dalsgaard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inmunologia y Genetica Aplicada SA
Original Assignee
Inmunologia y Genetica Aplicada SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES9300117A priority Critical patent/ES2065254B1/en
Application filed by Inmunologia y Genetica Aplicada SA filed Critical Inmunologia y Genetica Aplicada SA
Priority to DE69415462T priority patent/DE69415462T2/en
Priority to DK94905108T priority patent/DK0647655T3/en
Priority to CA002132742A priority patent/CA2132742C/en
Priority to EP94905108A priority patent/EP0647655B1/en
Priority to PCT/ES1994/000006 priority patent/WO1994017098A1/en
Priority to AT94905108T priority patent/ATE174929T1/en
Priority to US08/307,724 priority patent/US5785974A/en
Priority to NZ259882A priority patent/NZ259882A/en
Priority to AU70048/94A priority patent/AU680264B2/en
Publication of ES2065254A1 publication Critical patent/ES2065254A1/en
Application granted granted Critical
Publication of ES2065254B1 publication Critical patent/ES2065254B1/en
Priority to GR990400812T priority patent/GR3029727T3/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Peptides and synthetic vaccines against canine Parvovirus and other related viruses. Synthetic peptides are described which are able to produce neutralizing antibodies against canine Parvovirus (CPV). These peptides correspond to antigenic sites located in the amino terminal end of the VP2 of CPV which, linked to carrier proteins or other immunogenic complexes, are found to be useful for formulating vaccines against CPV and other related viruses such as the feline panleucopenia virus (FPLV) and the mink enteritis virus (MEV).
ES9300117A 1993-01-23 1993-01-23 PEPTIDES AND SYNTHETIC VACCINES AGAINST CANINE PARVOVIRUSES AND OTHER RELATED VIRUSES. Expired - Fee Related ES2065254B1 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
ES9300117A ES2065254B1 (en) 1993-01-23 1993-01-23 PEPTIDES AND SYNTHETIC VACCINES AGAINST CANINE PARVOVIRUSES AND OTHER RELATED VIRUSES.
NZ259882A NZ259882A (en) 1993-01-23 1994-01-21 Synthetic peptides and vaccines against parvoviruses
CA002132742A CA2132742C (en) 1993-01-23 1994-01-21 Synthetic peptides and vaccines against parvovirus
EP94905108A EP0647655B1 (en) 1993-01-23 1994-01-21 Synthetic peptides and vaccines against parvovirus
PCT/ES1994/000006 WO1994017098A1 (en) 1993-01-23 1994-01-21 Synthetic peptides and vaccines against parvovirus
AT94905108T ATE174929T1 (en) 1993-01-23 1994-01-21 SYNTHETIC PEPTIDES AND VACCINES AGAINST PARVOVIRUS
DE69415462T DE69415462T2 (en) 1993-01-23 1994-01-21 SYNTHETIC PEPTIDES AND VACCINE AGAINST PARVOVIRUS
DK94905108T DK0647655T3 (en) 1993-01-23 1994-01-21 Synthetic peptides and vaccines against parvovirus
AU70048/94A AU680264B2 (en) 1993-01-23 1994-01-21 Synthetic peptides and vaccines against parvovirus
US08/307,724 US5785974A (en) 1993-01-23 1994-01-21 Synthetic peptides and vaccines against parvovirus
GR990400812T GR3029727T3 (en) 1993-01-23 1999-03-18 Synthetic peptides and vaccines against parvovirus.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9300117A ES2065254B1 (en) 1993-01-23 1993-01-23 PEPTIDES AND SYNTHETIC VACCINES AGAINST CANINE PARVOVIRUSES AND OTHER RELATED VIRUSES.

Publications (2)

Publication Number Publication Date
ES2065254A1 true ES2065254A1 (en) 1995-02-01
ES2065254B1 ES2065254B1 (en) 1995-07-16

Family

ID=8280539

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9300117A Expired - Fee Related ES2065254B1 (en) 1993-01-23 1993-01-23 PEPTIDES AND SYNTHETIC VACCINES AGAINST CANINE PARVOVIRUSES AND OTHER RELATED VIRUSES.

Country Status (1)

Country Link
ES (1) ES2065254B1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0044710A1 (en) * 1980-07-17 1982-01-27 Scripps Clinic And Research Foundation Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom
ES2026826A6 (en) * 1991-03-26 1992-05-01 Ercros Sa Method for producing a subunit vaccine against the canine parvovirus and other related viruses.
ES2029938A6 (en) * 1990-07-31 1992-10-01 Ercros Sa Method for obtaining peptides and fusion recombinant proteins from the VP2 sub-unit of canine parvovirus CPV, and its use in methods of diagnosis and the formulation of vaccines

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0044710A1 (en) * 1980-07-17 1982-01-27 Scripps Clinic And Research Foundation Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom
ES2029938A6 (en) * 1990-07-31 1992-10-01 Ercros Sa Method for obtaining peptides and fusion recombinant proteins from the VP2 sub-unit of canine parvovirus CPV, and its use in methods of diagnosis and the formulation of vaccines
ES2026826A6 (en) * 1991-03-26 1992-05-01 Ercros Sa Method for producing a subunit vaccine against the canine parvovirus and other related viruses.

Also Published As

Publication number Publication date
ES2065254B1 (en) 1995-07-16

Similar Documents

Publication Publication Date Title
FI943591A7 (en) Synthetic Haemophilus influenzae combination vaccine
NZ503763A (en) Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use
ES2178000T3 (en) COMPOSITIONS AND METHODS TO TREAT INFECTIONS USING INDOLICIDINE ANALOGS.
RU95105991A (en) Conjugate, vaccine, methods of immunogenicity enhancement, methods of immunization
NO329875B1 (en) Isolated DNA sequence encoding swine reproductive and respiratory syndrome virus (PRRSV), a composition comprising the polypeptides encoded therein, a composition for inducing antibodies against PRRSV, use of a vaccine preparation composition and methods for distinguishing PRRSV strain ISU. 55 from other PRRSV strains.
DE69637914D1 (en) VEGETABLE AGAINST VIRUS RESPONSIBLE FOR RESPIRATORY AND REPRODUCTIVE DISEASES IN PIGS
ATE123035T1 (en) PRE-S-GEN ENCODED HEPATITIS-B IMMUNOGENIC PEPTIDES, VACCINES, DIAGNOSTICS AND SYNTHETIC LIPIDIC VEBIAL CARRIERS.
DK0585943T3 (en) Soluble ligands for CD40
CY1111831T1 (en) MAG FAMILY-DIGITAL ANTIGEN-DERIVATIVES FROM MAGE FAMILY AND NUCLEAR ACID SEQUENCES CODING THESE, WHILE USING THEM
AU3234295A (en) Influenza virus subunit conjugates
CA2132742A1 (en) Synthetic Peptides and Vaccines Against Parvovirus
SG63621A1 (en) Cytotoxic t lymphocyte-inducing lipopeptides and use as vaccines
IL109790A0 (en) Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines
ATE221786T1 (en) SYNTHETIC VACCINE FOR PROTECTION AGAINST HUMAN IMMUNO DEFICIENCY VIRUS INFECTIONS
RU94040393A (en) Synthetic peptides for vaccine against german measles
AU2363301A (en) Method for reducing the immunogenicity of heterologous proteins by elimination of t-cell epitopes
WO2000012122A3 (en) Low-molecular fragments of hyaluronic acid for the preparation of vaccines
EA200100395A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING DNA FRAGMENTS ENCODING ANTIGENIC PROTEIN COATING ANTI-ANTITROTHAL EFFECT
ES2065254A1 (en) Peptides and synthetic vaccines against canine Parvovirus and other related viruses
GB2299994A (en) Equine arteritis virus peptides antibodies and their use in a diagnostic test
ES1027961U (en) Advertising support for pushchairs. (Machine-translation by Google Translate, not legally binding)
Alekseeva et al. Chemical fragmentation by o-iodosobenzoic acid of alpha-chain of histidine decarboxylase from Micrococcus sp. n. AT tryptophan residues.
BRPI0009746B8 (en) pg-pviii plasmid-containing carrier molecule comprising a sequence encoding a part of a lissavirus glycoprotein containing at least lissavirus glycoprotein site iii but not containing site ii, and, immunogenic composition
ES2012815A6 (en) Vaccine against melanoma
BR0016740A (en) Cryptosporidium sporozoite antigens

Legal Events

Date Code Title Description
FD2A Announcement of lapse in spain

Effective date: 20141120